The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease.

Brain, Behavior, and Immunity
Itzia Jimenez-FerrerMaria Swanberg

Abstract

Abnormal folding, aggregation and spreading of alpha-synuclein (αsyn) is a mechanistic hypothesis for the progressive neuropathology in Parkinson's disease (PD). Spread of αsyn between cells is supported by clinical, neuropathological and experimental evidence. It has been proposed that a pro-inflammatory micro-environment in response to αsyn can promote its aggregation. We have previously shown that allelic differences in the major histocompatibility complex class two transactivator (Mhc2ta) gene, located in the VRA4 locus, alter MHCII expression levels, microglial activation and antigen presentation capacity in rats upon human αsyn over-expression. In addition, Mhc2ta regulated dopaminergic neurodegeneration and the extent of motor impairment. The purpose of this study was to determine whether Mhc2ta regulates αsyn aggregation, propagation and dopaminergic pathology in an αsyn pre-formed fibril (PFF)-seeded in vivo model of PD. The DA and DA.VRA4 congenic rat strains share background genome but display differential microglial antigen presenting capacity due to different Mhc2ta alleles in the VRA4 locus. PFFs of human αsyn or BSA solution were injected unilaterally to the striatum of DA and DA.VRA4 rats two weeks after ipsilat...Continue Reading

References

Jan 1, 1988·Acta Neuropathologica·P L McGeerE G McGeer
Dec 1, 1980·Journal of Neuroscience Methods·G PaxinosP C Emson
May 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·M G SpillantiniM Goedert
Jan 29, 2002·Nature Cell Biology·Hideo FujiwaraTakeshi Iwatsubo
Dec 25, 2002·Neurobiology of Aging·Heiko BraakEva Braak
Aug 29, 2003·European Neurology·J B LampeH Reichmann
Jun 7, 2005·Journal of Neuroinflammation·Emilie CroisierManuel B Graeber
Feb 23, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Karin HarneskFredrik Piehl
Apr 9, 2008·Nature Medicine·Jeffrey H KordowerC Warren Olanow
Nov 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Kelvin C LukVirginia M-Y Lee
Jan 20, 2011·The Journal of Clinical Investigation·Christian HansenPatrik Brundin
May 24, 2011·Neurobiology of Disease·Jeffrey H KordowerTimothy J Collier
Jun 7, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Ashley S HarmsDavid G Standaert
Nov 5, 2013·American Journal of Human Genetics·William T WissemannHaydeh Payami
Sep 14, 2017·Proceedings of the National Academy of Sciences of the United States of America·Poonam ThakurAnders Björklund
Oct 13, 2017·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·D James SurmeierGlenda M Halliday
Oct 13, 2017·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Patrik Brundin, Ronald Melki
May 3, 2018·Journal of Neuroinflammation·Megan F DuffyCaryl E Sortwell
Aug 20, 2019·Molecular Neurodegeneration·Sonia GeorgePatrik Brundin

❮ Previous
Next ❯

Citations

Feb 13, 2021·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Tai WangYuming Xu
Feb 14, 2021·Journal of Parkinson's Disease·Sonia GeorgePatrik Brundin
Jun 3, 2021·International Journal of Molecular Sciences·Panagiota Mavroeidi, Maria Xilouri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.